Education
About Us
Working with TipRanks
Follow Us
Bioxyne Limited (AU:BXN)
:BXN
Total Valuation
Bioxyne Limited has a market cap or net worth of AU$54.12M. The enterprise value is ―.
Market CapAU$54.12M
Enterprise Value―
Share Statistics
Bioxyne Limited has 2,164,828,600 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding2,164,828,600
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Bioxyne Limited’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.
Return on Equity (ROE)―
Return on Assets (ROA)―
Return on Invested Capital (ROIC)―
Return on Capital Employed (ROCE)―
Revenue Per Employee582.81K
Profits Per Employee-799.94K
Employee Count16
Asset Turnover―
Inventory Turnover―
Valuation Ratios
The current PE Ratio of Bioxyne Limited is ―. Bioxyne Limited’s PEG ratio is ―.
PE Ratio―
PS Ratio0.00
PB Ratio―
Price to Fair Value―
Price to FCF―
Price to Operating Cash Flow―
PEG Ratio―
Income Statement
In the last 12 months, Bioxyne Limited had revenue of 9.33M and earned -13.33M in profits. Earnings per share was -0.01.
Revenue9.33M
Gross Profit1.71M
Operating Income-1.66M
Pretax Income-13.29M
Net Income-13.33M
EBITDA-1.66M
Earnings Per Share (EPS)-0.01
Cash Flow
In the last 12 months, operating cash flow was -3.59M and capital expenditures -178.47K, giving a free cash flow of -3.77M billion.
Operating Cash Flow-3.59M
Free Cash Flow-3.77M
Free Cash Flow per Share>-0.01
Dividends & Yields
Bioxyne Limited pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.43
52-Week Price Change100.00%
50-Day Moving Average0.02
200-Day Moving Average―
Relative Strength Index (RSI)45.20
Average Volume (3m)2.56M
Important Dates
Bioxyne Limited upcoming earnings date is Aug 27, 2025, TBA Not Confirmed.
Last Earnings DateFeb 27, 2025
Next Earnings DateAug 27, 2025
Ex-Dividend Date―
Financial Position
Bioxyne Limited as a current ratio of ―, with Debt / Equity ratio of ―
Current Ratio―
Quick Ratio―
Debt to Market Cap―
Net Debt to EBITDA―
Interest Coverage Ratio―
Taxes
In the past 12 months, Bioxyne Limited has paid -310.64K in taxes.
Income Tax-310.64K
Effective Tax Rate―
Enterprise Valuation
Bioxyne Limited EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.
EV to Sales―
EV to EBITDA―
EV to Free Cash Flow―
EV to Operating Cash Flow―
Balance Sheet
Bioxyne Limited has AU$1.03M in cash and marketable securities with AU$673.72K in debt, giving a net cash position of -AU$354.27K billion.
Cash & Marketable SecuritiesAU$1.03M
Total DebtAU$673.72K
Net Cash-AU$354.27K
Net Cash Per Share>-AU$0.01
Tangible Book Value Per Share―
Margins
Gross margin is ―, with operating margin of ―, and net profit margin of ―.
Gross Margin―
Operating Margin―
Pretax Margin―
Net Profit Margin―
EBITDA Margin―
EBIT Margin―
Analyst Forecast
The average price target for Bioxyne Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast98.57%
EPS Growth Forecast―